Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 29, 2015 11:19 AM ET

Healthcare Providers and Services

Company Overview of Hadassah Medical Organisation (HMO)

Company Overview

Hadassah Medical Organization (HMO) is a medical and research institution that operates Hadassah University Hospitals at Ein Kerem and Mt. Scopus and associated outpatient and day-care services. The company also owns Hadassah Community Health Center in Kiryat Hayovel, which provides clinical care and serves as a demonstration center for new programs in primary care, family medicine, mother and child health, and public health. HMO has four departments: Osteoporosis Institute, Early Detection of Malignancies, Dietetic Service, and Center for Complementary (Integrative) Medicine. HMO was founded in 1912 and is headquartered in Jerusalem, Israel.

Kiryat Hadassah

Jerusalem,  91120


Founded in 1912


972 2 677 7013


972 2 677 6078

Key Executives for Hadassah Medical Organisation (HMO)

Chief Executive Officer
Director General
Age: 65
Head of Bone Marrow Transplantation, Cancer Immunotherapy Department, and Head of Cell Therapy and Transplantation Research Center
Compensation as of Fiscal Year 2015.

Hadassah Medical Organisation (HMO) Key Developments

Pluristem and Hadassah Medical Center Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant Outcomes

Pluristem Therapeutics Inc. announced that it has entered into a long-term collaboration agreement with Hadassah Medical Center in Jerusalem. The medical center's Department of Bone Marrow Transplantation and Cancer Immunotherapy, headed by Professor Reuven Or, will use preclinical models to assess the potential efficacy of PLX-RAD cells for treatment and prevention of hematological deficiencies and complications of bone marrow and umbilical cord blood transplantation. PLX-RAD cells are Pluristem's second cell therapy product candidate.

Hadassah Medical Organisation (HMO) Presents at The Economist Health Care Forum, Sep-17-2014 10:30 AM

Hadassah Medical Organisation (HMO) Presents at The Economist Health Care Forum, Sep-17-2014 10:30 AM. Venue: Seaport Boston Hotel, 1 Seaport Lane, Boston, MA 02210, United States. Speakers: Osnat Levtzion-Korach, Chief executive, Hadassah Mount Scopus University Hospital.

Hadassah Medical Center Announces Management Changes

Avigdor Kaplan is stepping down as CEO of Hadassah Medical Center. Prof. Tamar Peretz will fill the CEO role for the time being. Tamar Peretz is head of Haddasah's Sharett Institute of Oncology. Kaplan said that he could not accept the agreement between the Hadassah organization and the Finance and Health ministries that for the duration of the seven year period of the hospital's recovery plan, a supervisory financial controller would be appointed on behalf of the state.

Similar Private Companies By Industry

Company Name Region
Natali-Seculife Middle East/Africa
Salomon, Levin and Elstein Ltd. Middle East/Africa
Aramon Israel Middle East/Africa
Medison Ltd. Middle East/Africa
Johnson & Johnson Medical Israel Middle East/Africa

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Hadassah Medical Organisation (HMO), please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at